Coronary Heart Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Signed informed consent for the study; 2. Age>=65 years old and < 80 years old; 3. Diagnosed coronary heart disease for more than 1 month, including myocardial infarction and angina; Angina was only included in cases of angina undergoing percutaneous transluminal coronary angioplasty/stenting, and/or coronary artery bypass grafting; 4. It is expected that there will be no interruption in participating in the project within 1 year; 5. Clear awareness, comprehension ability, able to communicate with the researcher in writing or language, and able to cooperate with the completion of the research process; 6. Those who have not participated in drug clinical trials or other investigators during the study cycle.
Exclusion criteria
Exclusion criteria: 1. The risk stratification of exercise rehabilitation in patients with coronary heart disease is high-risk; 2. Unstable angina pectoris or myocardial infarction, worsening heart failure, acute deep vein thrombosis, pulmonary embolism, myocarditis or endocarditis within 1 month; 3. Patients with serious diseases such as hemiplegia or life expectancy of less than 1 year; 4. Those who are unable to exercise due to fractures, joint instability or other physical diseases; 5. Those who have skin diseases or injuries around the wearing part of the monitoring equipment; 6. Those who are mentally ill, epilepsy or other diseases that cause involuntary physical movement or are unable to cooperate; 7. Those with limb disability; 8. Tourette's syndrome or inability to maintain arm stability; 9. Those who are judged by the investigator not to meet the conditions for participating in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximal oxygen consumption;Blood pressure level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Blood glucose level;Lipid levels;Re - hospitalization;Cost-effectiveness;Adverse Events;Compliance and satisfaction of the management group ;Differences in MACE events ; | — |
Countries
China
Contacts
Fuwai Hospital, Chinese Academy of Medical Science